ArticleJournal of sleep research2026
Insomnia Subtypes in Clinical Population According to the Insomnia Type Questionnaire (ITQ): A Multi-Centre Study in Spanish Sleep Clinics.
Article in Journal of sleep research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Insomnia Subtypes in Clinical Population According to the Insomnia Type Questionnaire (ITQ): A Multi-Centre Study in Spanish Sleep Clinics.Journal of sleep research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The lack of robust subtyping for insomnia disorder (ID) led to its current classification as a uniform condition. A novel approach to subtyping ID developed a new tool, the insomnia type questionnaire (ITQ). Our research aimed to assess whether the ID subtypes identified in the general population could also be found in ID patients referred to sleep clinics in a multi-centre study throughout Spain, and to gather insights for the management of complex ID patients. The ITQ classified ID patients into the five previously described subtypes: Type 1 = 35.1%, Type 2 = 12%, Type 3 = 46.7%, Type 4 = 5.8% and Type 5 = 0.4%. Compared to the general population, there was an overrepresentation of Types 1 and 3, consistently across all participating clinical centres. The total self-reported sleep duration was 4.7 (SD 1.2) h, with no significant differences between subtypes. Type 1 patients had significantly higher scores in the Insomnia Severity Index, Inventory of Depressive Symptomatology self-rated and State-Trait Anxiety Inventory. Type 3 patients were more worried about their sleep. Type 4 had the lowest depression and anxiety scores. ITQ subtyping showed that ID patients attending sleep clinics had high scores in depression, specially Type 1 patients, who probably need a differentiated therapeutic approach. The over-representation of Type 3 patients suggests that they are more worried about their sleep than the other subtypes. These findings highlight the difficulties faced by sleep clinicians to treat complex and refractory-toto-treatment ID patients and those with comorbid insomnia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.